Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Clinical trial NCT02486718 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02486718
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-31
- Primary completion
- 2024-01-26
- Enrollment
- 1280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.